Stanton Glantz, PhD

Professor

RESEARCH INTERESTS: Dr. Glantz conducts research on a wide range of topics ranging from the health effects of e-cigarettes and secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz' work has expanded to include cannabis policy, because of the interactions between tobacco and cannabis.

Dr. Glantz conducts research on a wide range of issues ranging from the effects of e-cigarettes and secondhand smoke on the heart through the reductions in heart attacks observed when smokefree policies are enacted, to how the tobacco industry fights tobacco control programs. His research on the effects of secondhand smoke on blood and blood vessels has helped explain why, in terms of heart disease, the effects of secondhand smoke are nearly as large as smoking. Consistent with what would be expected from the biology of secondhand smoke, he demonstrated a large and rapid reduction in the number of people admitted to the hospital with heart attacks in Helena, Montana, after that community made all workplaces and public places smokefree. His work in this area was identified as one of the “top research advances for 2005" by the American Heart Association. He was one of the first people to argue that controlling youth access to tobacco products was not an effective tobacco control strategy and to identify the importance of young adults (not just teens) as targets for the tobacco industry and efforts at smoking cessation and tobacco use prevention.

He is a globally recognized expert on e-cigarettes and is applying his understanding of the tobacco industry to the emerging marijuana industry as well as the sugar industry.

Dr. Glantz is Principal Investigator for the $40 million 10 year Tobacco Centers of Regulatory Science (TCORS) that was first funded in September 2013 and renewed for another 5 years in 2018 as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health. The TCORS takes a broad interdisciplinary approach to understanding new tobacco products by integrating pulmonary, cardiovascular, pharmacology, behavioral and economic research to understand the effects of new products and inform tobacco product regulation.

He is author or coauthor of numerous publications on tobacco control, including secondhand smoke, e-cigarettes and heated tobacco products as well as cannabis policy. He has also contributed to research on how the sugar industry has worked to shape the scientific understanding of the effects of sugar consumption.

He has written several books, including the widely used Primer of Biostatistics (which has been translated into Japanese, French, Russian, German, Italian, Japanese and Spanish, and Primer of Applied Regression and Analysis of Variance). In total, he is the author of 5 books and over 400 scientific papers, including the first major review (published in Circulation) which identified involuntary smoking as a cause of heart disease and the landmark July 19, 1995 issue of JAMA on the Brown and Williamson documents, which showed that the tobacco industry knew nicotine was addictive and that smoking caused cancer 40 years ago. This publication was followed up with his book, The Cigarette Papers, which has played a key role in the ongoing litigation surrounding the tobacco industry. His book Tobacco Wars: Inside the California Battles chronicles the last quarter century of battles against the tobacco industry in California. He also wrote Tobacco: Biology and Politics for high school students and The Uninvited Guest, a story about secondhand smoke, for second graders, and Bad Acts, which tells the inside story of the US Department of Justices' massive racketeering lawsuit against the tobacco industry. He ran the successful TobaccoScam project that helped break the historic alliance between the tobacco and hospitality industries. He is now running an educational project, SmokeFreeMovies.ucsf.edu, which is working to end use of movies to promote tobacco.

Working with the UCSF Library, he has taken the lead in making over 90 million pages of previously secret tobacco industry documents available to the entire world via the internet through the UCSF Truth Tobacco Industry Documents Library. More recently, he has worked with the Library and other colleagues to expand collections on the food (sugar), chemical, fossil fuel and pharma industries. This effort has help create a whole new area of scientific investigation based on tobacco industry documents.

Dr. Glantz served as founding Director of the UCSF Center for Tobacco Control Research and Education for 20 years, until he stepped down from that position in 2020. He is a member of the Helen Diller Familiy Comprehensive Cancer Center Tobacco Program, Cardiovascular Research Institute and Philip R. Lee Instiute for Heatlh Policy Studies.

He served for 10 years as an Associate Editor of the Journal of the American College of Cardiology and is an academic editor for PLOS One. He has been a member of the California State Scientific Review Panel on Toxic Air Contaminants since 1986. He was elected to the National Academy of Medicine (formerly Institute of Medicine) in 2005.

He has traveled widely and lectured on scientific and policy issues related to e-cigarettes, clean indoor air, smoking in the movies, and effective tobacco and cannabis control strategies. His work has attracted considerable attention from the tobacco industry, which has sued the University of California (unsuccessfully) twice in an effort to stop Prof. Glantz' work.
Honors and Awards
  • Luther Terry Distinguished Career in Tobacco Control, American Cancer Society, 2009
  • Award of Meritorious Achievement, American Heart Association, 2006
  • Elected to Institute of Medicine, 2005
  • Joseph Cullen Memorial Award, American Society of Preventive Oncology, 2005
  • Innovators in Substance Abuse Prevention, Robert Wood Johnson Foundation, 2000-2003
  • UCSF Chancellor's Award for Public Service, 1997
  • Alton Ochsner Award of Special Recognition, 1996
  • James Madison Freedom of Information Award, Society of Professional Journalists, 1996
  • 100 Newsmakers of 1995, Newsweek, 1995
  • NSF Graduate Fellowship, 1969-1972
  • Eagle Scout, 1960
Publications

  1. Bhatta DN, Glantz SA. The proper approach to assessing the impact of the fact that e-cigarettes were not available before 2007. Addiction (Abingdon, England) 2020. PMID: 32794248


  2. Lempert LK, Glantz S. Analysis of FDA's IQOS marketing authorisation and its policy impacts. Tobacco control 2020. PMID: 32601147


  3. Apollonio DE, Glantz SA. Tobacco industry promotions and pricing after tax increases: An analysis of internal industry documents. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2019. PMID: 31058282


  4. Bowling CM, Hafez AY, Glantz SA. Public Health and Medicine's Need to Respond to Cannabis Commercialization in the United States: A Commentary. Journal of psychoactive drugs 2020. PMID: 32429772


  5. Patanavanich R, Glantz SA. Smoking is Associated with COVID-19 Progression: A Meta-Analysis. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2020. PMID: 32399563


  6. Bhatta DN, Crosbie E, Bialous SA, Glantz S. Defending comprehensive tobacco control policy implementation in Nepal from tobacco industry interference (2011-2018). Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2020. PMID: 32309853


  7. Vyas P, Ling P, Gordon B, Callewaert J, Dang A, Smith D, Chan B, Glantz S. Compliance with San Francisco's flavoured tobacco sales prohibition. Tobacco control 2020. PMID: 32300030


  8. Patanavanich R, Glantz SA. Smoking is Associated with COVID-19 Progression: A Meta-Analysis. medRxiv : the preprint server for health sciences 2020. PMID: 32511645


  9. Arora M, Nazar GP, Chugh A, Rawal T, Shrivastava S, Sinha P, Munish VG, Tullu FT, Schotte K, Polansky JR, Glantz S. Tobacco imagery in on-demand streaming content popular among adolescents and young adults in India: implications for global tobacco control. Tobacco control 2020. PMID: 32273433


  10. Orenstein DG, Glantz SA. The Grassroots of Grass: Cannabis Legalization Ballot Initiative Campaign Contributions and Outcomes, 2004-2016. Journal of health politics, policy and law 2019. PMID: 31675092


  13. Nguyen KH, Glantz SA, Palmer CN, Schmidt LA. Transferring Racial/Ethnic Marketing Strategies From Tobacco to Food Corporations: Philip Morris and Kraft General Foods. American journal of public health 2020. PMID: 31944842


  14. Yadav A, Ling P, Glantz S. Smokeless tobacco industry's brand stretching in India. Tobacco control 2020. PMID: 31919227


  15. Psotka MA, Rushakoff J, Glantz SA, De Marco T, Fleischmann KE. The Association Between Secondhand Smoke Exposure and Survival for Patients with Heart Failure. Journal of Cardiac Failure 2020. PMID: 31926217


  17. Bhatta DN, Glantz SA. Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. American journal of preventive medicine 2019. PMID: 31859175


  18. Tynan MA, Polansky JR, Driscoll D, Garcia C, Glantz SA. Tobacco Use in Top-Grossing Movies - United States, 2010-2018. MMWR. Morbidity and mortality weekly report 2019. PMID: 31671080


  19. Alzahrani T, Glantz SA. Adding Data From 2015 Strengthens the Association Between E-Cigarette Use and Myocardial Infarction. American journal of preventive medicine 2019. PMID: 31542134


  20. Bhatta DN, Bialous S, Crosbie E, Glantz S. Exceeding FCTC obligations: Nepal overcoming tobacco industry interference to enact a comprehensive tobacco control policy. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2019. PMID: 31535694


  21. Hafez AY, Gonzalez M, Kulik MC, Vijayaraghavan M, Glantz SA. Uneven Access to Smoke-Free Laws and Policies and Its Effect on Health Equity in the United States: 2000-2019. American journal of public health 2019. PMID: 31536405


  23. Bhatta D, Crosbie E, Bialous S, Glantz S. Tobacco control in Nepal during a time of government turmoil (1960-2006). Tobacco control 2019. PMID: 31363061


  24. Egbe CO, Bialous SA, Glantz S. FCTC Implementation in Nigeria: Lessons for Low and Middle-Income Countries. 2018. PMID: 29660032


  26. Yang YT, Glantz S. San Francisco Voters End the Sale of Flavored Tobacco Products. Annals of internal medicine 2019. PMID: 31207627


  27. Bowling C, Glantz SA. Civic Engagement in California Cannabis Policy Development. Journal of psychoactive drugs 2019. PMID: 31187690


  28. Bhatta DN, Glantz SA. Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health. Journal of the American Heart Association 2019. PMID: 31165662


  31. Chien YN, Gao W, Sanna M, Chen PL, Chen YH, Glantz S, Chiou HY. Electronic Cigarette Use and Smoking Initiation in Taiwan: Evidence from the First Prospective Study in Asia. International journal of environmental research and public health 2019. PMID: 30935027


  33. Nguyen KH, Glantz SA, Palmer CN, Schmidt LA. Tobacco industry involvement in children's sugary drinks market. BMJ (Clinical research ed.) 2019. PMID: 30872273


  37. Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S. Estimating the long-run relationship between state cigarette taxes and county life expectancy. Tobacco control 2019. PMID: 30705247


  39. Bowling CM, Glantz SA. Conflict of Interest Provisions in State Laws Governing Medical and Adult Use Cannabis. American journal of public health 2019. PMID: 30676801


  40. Crosbie E, Bialous S, Glantz SA. Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies. Tobacco control 2019. PMID: 30659106


  41. Alzahrani T, Pena I, Temesgen N, Glantz SA. E-cigarettes: Stick to the Evidence. American journal of preventive medicine 2019. PMID: 30573144


  42. Glantz SA. Heated tobacco products: the example of IQOS. Tobacco control 2018. PMID: 30352841


  43. Halvorson RT, Stewart CC, Thakur A, Glantz SA. Scientific Quality of Health-Related Articles in Specialty Cannabis and General Newspapers in San Francisco. Journal of health communication 2018. PMID: 30358488


  44. Yang YT, Glantz S. San Francisco Voters End the Sale of Flavored Tobacco Products Despite Strong Industry Opposition. Annals of internal medicine 2018. PMID: 30304334


  45. Lempert LK, Glantz SA. Heated tobacco product regulation under US law and the FCTC. Tobacco control 2018. PMID: 30291201


  47. van der Eijk Y, Bialous S, Glantz SA. Authors' Response. Pediatrics 2018. PMID: 30266871


  50. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association Between Electronic Cigarette Use and Myocardial Infarction. American journal of preventive medicine 2018. PMID: 30166079


  52. Ling PM, Glantz SA. Tobacco company strategies to identify and promote the benefits of nicotine. Tobacco control 2018. PMID: 30093414


  53. Watkins SL, Glantz SA, Chaffee BW. Noncigarette Tobacco Products-Gateway or Diversion?-Reply. JAMA pediatrics 2018. PMID: 29868756


  56. Barry RA, Glantz SA. Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard. Volume 108 of Issue 7. American journal of public health 2018. PMID: 29874509


  58. Kearns C, Schmidt L, Apollonio D, Glantz S. The sugar industry's influence on policy. Science (New York, N.Y.) 2018. PMID: 29724946


  59. Glantz SA, Gardiner P. Local Movement to Ban Menthol Tobacco Products as a Result of Federal Inaction. Volume 178 of Issue 5. JAMA internal medicine 2018. PMID: 29507930


  60. van der Eijk Y, Bialous SA, Glantz S. The Tobacco Industry and Children's Rights. Volume 141 of Issue 5. Pediatrics 2018. PMID: 29712762


  61. Chaffee BW, Watkins SL, Glantz SA. Electronic Cigarette Use and Progression From Experimentation to Established Smoking. Volume 141 of Issue 4. Pediatrics 2018. PMID: 29507167


  62. Popova L, Thrul J, Glantz SA. Effects of Large Cigarette Warning Labels on Smokers' Expected Longevity. Volume 42 of Issue 2. 2018. PMID: 29458517


  63. Orenstein DG, Glantz SA. Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control. Volume 50 of Issue 1. 2018. PMID: 29438634


  64. Kulik MC, Lisha NE, Glantz SA. E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries. Volume 54 of Issue 4. 2018. PMID: 29449132


  65. Dutra LM, Glantz SA, Arrazola RA, King BA. Impact of E-Cigarette Minimum Legal Sale Age Laws on Current Cigarette Smoking. Volume 62 of Issue 5. 2018. PMID: 29422436


  68. Bialous SA, Glantz SA. The Challenges of Monitoring Illicit Trade Should Not Obscure the Success of Tobacco Tax Policy. Volume 108 of Issue 2. American journal of public health 2018. PMID: 29320293


  70. Glantz SA, Bareham DW. E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications. Volume 39. Annual review of public health 2018. PMID: 29323609


  71. Glantz SA, Halpern-Felsher B, Springer ML. Marijuana, Secondhand Smoke, and Social Acceptability. Volume 178 of Issue 1. JAMA internal medicine 2018. PMID: 29159409


  72. Hiatt RA, Sibley A, Fejerman L, Glantz S, Nguyen T, Pasick R, Palmer N, Perkins A, Potter MB, Somsouk M, Vargas RA, van 't Veer LJ, Ashworth A. The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer. Volume 37 of Issue 1. Health affairs (Project Hope) 2018. PMID: 29309234


  73. van der Eijk Y, Glantz SA. Tobacco industry attempts to frame smoking as a 'disability' under the 1990 Americans with Disabilities Act. Volume 12 of Issue 11. PloS one 2017. PMID: 29176829


  75. Yao T, Max W, Sung HY, Glantz SA, Goldberg RL, Wang JB, Wang Y, Lightwood J, Cataldo J. Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S. Volume 12 of Issue 11. PloS one 2017. PMID: 29112988


  76. Velicer C, St Helen G, Glantz SA. Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology. Volume 39 of Issue 1. 2017. PMID: 29116189


  77. van der Eijk Y, McDaniel PA, Glantz SA, Bialous SA. United Nations Global Compact: an 'Inroad' into the UN and reputation boost for the tobacco industry. 2017. PMID: 29097589


  79. Apollonio D, Glantz SA. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Volume 107 of Issue 10. American journal of public health 2017. PMID: 28817320


  81. Tynan MA, Polansky JR, Titus K, Atayeva R, Glantz SA. Tobacco Use in Top-Grossing Movies - United States, 2010-2016. Volume 66 of Issue 26. 2017. PMID: 28683057


  83. Russo AR, Solis AC, Villanti AC, Wipfli HL, Kern TT, Lawley RK, Collins LK, Abudayyeh HS, Chansky MC, Glantz SA, Samet JM, Benjamin EJ. Mentoring for Success in Tobacco Regulatory Science: A Qualitative Study. Volume 3 of Issue 3. 2017. PMID: 28758143


  84. Glantz SA, Rutherford JD. Here Comes Trouble: A Career as a Tobacco Control Activist. Volume 135 of Issue 23. Circulation 2017. PMID: 28584028


  85. Dutra L, Glantz S. We Agree on the Importance of Contextual and Temporal Accuracy When Studying Novel Tobacco Products. Volume 139 of Issue 5. Pediatrics 2017. PMID: 28557769


  86. Jiang N, Gonzalez M, Ling PM, Young-Wolff KC, Glantz SA. Smoke-Free Laws and Hazardous Drinking: A Cross-Sectional Study among U.S. Adults. Volume 14 of Issue 4. 2017. PMID: 28406443


  88. Uang R, Crosbie E, Glantz SA. Smokefree implementation in Colombia: Monitoring, outside funding, and business support. Volume 59 of Issue 2. 2017. PMID: 28562713


  89. Dutra LM, Glantz SA, Lisha NE, Song AV. Beyond experimentation: Five trajectories of cigarette smoking in a longitudinal sample of youth. Volume 12 of Issue 2. PloS one 2017. PMID: 28182748


  90. Dutra LM, Glantz SA. E-cigarettes and National Adolescent Cigarette Use: 2004-2014. Volume 139 of Issue 2. Pediatrics 2017. PMID: 28115540


  91. Fallin-Bennett A, Roditis M, Glantz SA. The carrot and the stick? Strategies to improve compliance with college campus tobacco policies. Volume 65 of Issue 2. 2016. PMID: 27869568


  92. Dutra LM, Grana R, Glantz SA. Philip Morris research on precursors to the modern e-cigarette since 1990. Volume 26 of Issue e2. 2016. PMID: 27852893


  93. Kearns CE, Schmidt LA, Glantz SA. Sugar Industry and Coronary Heart Disease Research: A Historical Analysis of Internal Industry Documents. Volume 176 of Issue 11. JAMA internal medicine 2016. PMID: 27617709


  95. Barry RA, Glantz S. A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry. Volume 13 of Issue 9. PLoS medicine 2016. PMID: 27676176


  96. Cox E, Barry RA, Glantz S. E-cigarette Policymaking by Local and State Governments: 2009-2014. Volume 94 of Issue 3. The Milbank quarterly 2016. PMID: 27620685


  98. Hopkinson NS, Millett C, Glantz S, Arnott D, McNeill A. UK government should fund stop smoking media campaigns not give tax breaks to films with smoking imagery. Volume 111 of Issue 11. 2016. PMID: 27363590


  99. Hiilamo H, Glantz S. FCTC followed by accelerated implementation of tobacco advertising bans. Volume 26 of Issue 4. 2016. PMID: 27471111


  100. Wang X, Derakhshandeh R, Liu J, Narayan S, Nabavizadeh P, Le S, Danforth OM, Pinnamaneni K, Rodriguez HJ, Luu E, Sievers RE, Schick SF, Glantz SA, Springer ML. One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function. Volume 5 of Issue 8. 2016. PMID: 27464788


  101. Yeh JS, Bullen C, Glantz SA. CLINICAL DECISIONS. E-Cigarettes and Smoking Cessation. Volume 374 of Issue 22. The New England journal of medicine 2016. PMID: 27248625


  102. Lempert LK, Glantz S. Packaging colour research by tobacco companies: the pack as a product characteristic. Volume 26 of Issue 3. 2016. PMID: 27255118


  104. Apollonio DE, Glantz SA. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Volume 106 of Issue 7. American journal of public health 2016. PMID: 27196658


  105. Lightwood J, Glantz SA. Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates. Volume 13 of Issue 5. PLoS medicine 2016. PMID: 27163933


  106. Lempert LK, Glantz SA. Implications of Tobacco Industry Research on Packaging Colors for Designing Health Warning Labels. Volume 18 of Issue 9. 2016. PMID: 27146637


  107. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation - Authors' reply. Volume 4 of Issue 6. The Lancet. Respiratory medicine 2016. PMID: 27133215


  108. Gendall P, Hoek J, Edwards R, Glantz S. Effect of Exposure to Smoking in Movies on Young Adult Smoking in New Zealand. Volume 11 of Issue 3. PloS one 2016. PMID: 26960189


  110. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Volume 4 of Issue 2. The Lancet. Respiratory medicine 2016. PMID: 26776875


  112. Liu J, Wang X, Narayan S, Glantz SA, Schick SF, Springer ML. Impairment of Endothelial Function by Little Cigar Secondhand Smoke. Volume 2 of Issue 1. 2016. PMID: 26753171


  113. Velicer C, Glantz SA. Hiding in the Shadows: Philip Morris and the Use of Third Parties to Oppose Ingredient Disclosure Regulations. Volume 10 of Issue 12. PloS one 2015. PMID: 26717245


  114. Cheng KW, Liu F, Gonzalez M, Glantz S. The Effects of Workplace Clean Indoor Air Law Coverage on Workers' Smoking-Related Outcomes. Volume 26 of Issue 2. Health economics 2015. PMID: 26639369


  115. Uang R, Hiilamo H, Glantz SA. Accelerated Adoption of Smoke-Free Laws After Ratification of the World Health Organization Framework Convention on Tobacco Control. Volume 106 of Issue 1. American journal of public health 2015. PMID: 26562125


  116. Popova L, Linde BD, Bursac Z, Talcott GW, Modayil MV, Little MA, Ling PM, Glantz SA, Klesges RC. Testing antismoking messages for Air Force trainees. Volume 25 of Issue 6. 2015. PMID: 26482786


  117. Jiang N, Gonzalez M, Ling PM, Glantz SA. Relationship of Smokefree Laws and Alcohol Use with Light and Intermittent Smoking and Quit Attempts among US Adults and Alcohol Users. Volume 10 of Issue 10. PloS one 2015. PMID: 26445314


  118. Kalkhoran S, Glantz SA. Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis. Volume 175 of Issue 10. JAMA internal medicine 2015. PMID: 26322924


  119. Song AV, Dutra LM, Neilands TB, Glantz SA. Association of Smoke-Free Laws With Lower Percentages of New and Current Smokers Among Adolescents and Young Adults: An 11-Year Longitudinal Study. Volume 169 of Issue 9. JAMA pediatrics 2015. PMID: 26348866


  120. Dixit S, Pletcher MJ, Vittinghoff E, Imburgia K, Maguire C, Whitman IR, Glantz SA, Olgin JE, Marcus GM. Secondhand smoke and atrial fibrillation: Data from the Health eHeart Study. Volume 13 of Issue 1. 2015. PMID: 26340844


  121. Fulmer EB, Neilands TB, Dube SR, Kuiper NM, Arrazola RA, Glantz SA. Protobacco Media Exposure and Youth Susceptibility to Smoking Cigarettes, Cigarette Experimentation, and Current Tobacco Use among US Youth. Volume 10 of Issue 8. PloS one 2015. PMID: 26308217


  122. Velicer C, Aguinaga-Bialous S, Glantz S. Tobacco companies' efforts to undermine ingredient disclosure: the Massachusetts benchmark study. Volume 25 of Issue 5. 2015. PMID: 26292701


  123. Kulik MC, Glantz SA. The smoking population in the USA and EU is softening not hardening. Volume 25 of Issue 4. 2015. PMID: 26108654


  124. Fallin A, Glantz SA. Tobacco-control policies in tobacco-growing states: where tobacco was king. Volume 93 of Issue 2. The Milbank quarterly 2015. PMID: 26044632


  125. Kalkhoran S, Sebrié EM, Sandoya E, Glantz SA. Effect of Uruguay's National 100% Smokefree Law on Emergency Visits for Bronchospasm. Volume 49 of Issue 1. 2015. PMID: 25997906


  126. Stevens D, Glantz S. Tobacco documents reveal questionable professional recertification by industry menthol expert. Volume 25 of Issue 3. 2015. PMID: 25967941


  128. Grana R, Benowitz N, Glantz S. Response to letter regarding article, "Electronic cigarettes: a scientific review". Volume 131 of Issue 6. Circulation 2015. PMID: 25815391


  129. Song AV, Glantz SA. Assessing tobacco regulation: moving beyond economists. Volume 24 of Issue 2. 2015. PMID: 25564284


  130. Benowitz NL, Gan Q, Goniewicz ML, Lu W, Xu J, Li X, Jacob P, Glantz S. Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers. Volume 24 of Issue e4. 2014. PMID: 25535294


  131. Fallin A, Roditis M, Glantz SA. Association of campus tobacco policies with secondhand smoke exposure, intention to smoke on campus, and attitudes about outdoor smoking restrictions. Volume 105 of Issue 6. American journal of public health 2014. PMID: 25521901


  132. Lempert LK, Grana R, Glantz SA. The importance of product definitions in US e-cigarette laws and regulations. Volume 25 of Issue e1. 2014. PMID: 25512432


  133. McKee M, Chapman S, Daube M, Glantz S. The debate on electronic cigarettes. Volume 384 of Issue 9960. Lancet (London, England) 2014. PMID: 25497194


  136. Hiilamo H, Glantz SA. Old wine in new bottles: tobacco industry's submission to European Commission tobacco product directive public consultation. Volume 119 of Issue 1. Health policy (Amsterdam, Netherlands) 2014. PMID: 25467283


  137. Dutra LM, Glantz SA. High international electronic cigarette use among never smoker adolescents. Volume 55 of Issue 5. 2014. PMID: 25344030


  138. Kostygina G, Glantz SA, Ling PM. Tobacco industry use of flavours to recruit new users of little cigars and cigarillos. Volume 25 of Issue 1. 2014. PMID: 25354674


  139. Yao T, Jiang N, Grana R, Ling PM, Glantz SA. A content analysis of electronic cigarette manufacturer websites in China. Volume 25 of Issue 2. 2014. PMID: 25335902


  140. Crosbie E, Gonzalez M, Glantz SA. Crosbie et Al. Respond. Volume 104 of Issue 12. American journal of public health 2014. PMID: 25320883


  141. Mamudu HM, Dadkar S, Veeranki SP, He Y, Barnes R, Glantz SA. Multiple streams approach to tobacco control policymaking in a tobacco-growing state. Volume 39 of Issue 4. 2014. PMID: 24370600


  142. Dutra LM, Glantz SA. Youth tobacco use and electronic cigarettes--reply. Volume 168 of Issue 8. JAMA pediatrics 2014. PMID: 25090297


  143. Crosbie E, Gonzalez M, Glantz SA. Health preemption behind closed doors: trade agreements and fast-track authority. Volume 104 of Issue 9. American journal of public health 2014. PMID: 25033124


  144. Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. Volume 168 of Issue 7. JAMA pediatrics 2014. PMID: 24604023


  147. Barry RA, Hiilamo H, Glantz SA. Waiting for the opportune moment: the tobacco industry and marijuana legalization. Volume 92 of Issue 2. The Milbank quarterly 2014. PMID: 24890245


  148. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Volume 129 of Issue 19. Circulation 2014. PMID: 24821826


  149. Grana RA, Ling PM, Benowitz N, Glantz S. Electronic cigarettes. Cardiology patient page. Volume 129 of Issue 19. Circulation 2014. PMID: 24821830


  150. Kalkhoran S, Glantz SA. Smoke-free policies: cleaning the air with money to spare. Volume 383 of Issue 9928. Lancet (London, England) 2014. PMID: 24680632


  151. Laposata E, Kennedy AP, Glantz SA. When tobacco targets direct democracy. Volume 39 of Issue 3. Journal of health politics, policy and law 2014. PMID: 24603083


  152. Gonzalez M, Sanders-Jackson A, Glantz SA. Association of strong smoke-free laws with dentists' advice to quit smoking, 2006-2007. Volume 104 of Issue 4. American journal of public health 2014. PMID: 24524506


  153. Ling PM, Lee YO, Hong J, Neilands TB, Jordan JW, Glantz SA. Social branding to decrease smoking among young adults in bars. Volume 104 of Issue 4. American journal of public health 2014. PMID: 24524502


  154. Brown-Johnson CG, England LJ, Glantz SA, Ling PM. Tobacco industry marketing to low socioeconomic status women in the U.S.A. Volume 23 of Issue e2. 2014. PMID: 24449249


  156. Song AV, Brown P, Glantz SA. When health policy and empirical evidence collide: the case of cigarette package warning labels and economic consumer surplus. Volume 104 of Issue 2. American journal of public health 2013. PMID: 24328661


  157. Pinnamaneni K, Sievers RE, Sharma R, Selchau AM, Gutierrez G, Nordsieck EJ, Su R, An S, Chen Q, Wang X, Derakhshandeh R, Aschbacher K, Heiss C, Glantz SA, Schick SF, Springer ML. Brief exposure to secondhand smoke reversibly impairs endothelial vasodilatory function. Volume 16 of Issue 5. 2013. PMID: 24302638


  160. Apollonio DE, Glantz SA, Bero LA. Term limits and the tobacco industry. Volume 104. Social science & medicine (1982) 2013. PMID: 24581055


  161. Cheng KW, Okechukwu CA, McMillen R, Glantz SA. Association between clean indoor air laws and voluntary smokefree rules in homes and cars. Volume 24 of Issue 2. 2013. PMID: 24114562


  163. Glantz SA, Gibbs E. Changes in ambulance calls after implementation of a smoke-free law and its extension to casinos. Volume 128 of Issue 8. Circulation 2013. PMID: 23918257


  164. Polansky J, Glantz S. Debate over tobacco and film ratings should be evidence-based. Volume 126 of Issue 1378. 2013. PMID: 24045321


  167. Sanders-Jackson A, Gonzalez M, Zerbe B, Song AV, Glantz SA. The pattern of indoor smoking restriction law transitions, 1970-2009: laws are sticky. Volume 103 of Issue 8. American journal of public health 2013. PMID: 23763408


  169. Sebrié EM, Sandoya E, Bianco E, Hyland A, Cummings KM, Glantz SA. Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay: experience through 2010. Volume 23 of Issue 6. 2013. PMID: 25324157


  170. Sterling K, Berg CJ, Thomas AN, Glantz SA, Ahluwalia JS. Factors associated with small cigar use among college students. Volume 37 of Issue 3. 2013. PMID: 23985179


  171. Lee JT, Agrawal S, Basu S, Glantz SA, Millett C. Association between smoke-free workplace and second-hand smoke exposure at home in India. Volume 23 of Issue 4. 2013. PMID: 23525121


  172. Gonzalez M, Sanders-Jackson A, Song AV, Cheng KW, Glantz SA. Strong smoke-free law coverage in the United States by race/ethnicity: 2000-2009. Volume 103 of Issue 5. American journal of public health 2013. PMID: 23488507


  174. Fallin A, Grana R, Glantz SA. 'To quarterback behind the scenes, third-party efforts': the tobacco industry and the Tea Party. Volume 23 of Issue 4. 2013. PMID: 23396417


  175. Millett C, Lee JT, Laverty AA, Glantz SA, Majeed A. Hospital admissions for childhood asthma after smoke-free legislation in England. Volume 131 of Issue 2. Pediatrics 2013. PMID: 23339216


  176. Glantz SA. Slaying the Jabberwock: the link between strong smokefree policies and drops in acute myocardial infarctions survives the funnel plot. Volume 168 of Issue 2. International journal of cardiology 2012. PMID: 23270745


  181. Tan CE, Glantz SA. SMOKEFREE AIR: AN IMPORTANT STRATEGY TO REDUCING HEART ATTACKS AROUND THE WORLD. Volume 7 of Issue 2. 2012. PMID: 23710433


  182. Frey PF, Ganz P, Hsue PY, Benowitz NL, Glantz SA, Balmes JR, Schick SF. The exposure-dependent effects of aged secondhand smoke on endothelial function. Volume 59 of Issue 21. Journal of the American College of Cardiology 2012. PMID: 22595411


  183. Sebrié EM, Schoj V, Travers MJ, McGaw B, Glantz SA. Smokefree policies in Latin America and the Caribbean: making progress. Volume 9 of Issue 5. 2012. PMID: 22754484


  184. Schane RE, Prochaska JJ, Glantz SA. Counseling nondaily smokers about secondhand smoke as a cessation message: a pilot randomized trial. Volume 15 of Issue 2. 2012. PMID: 22592447


  185. Lee S, Glantz SA. South Korea: 'KT&G Sangsang Univ.' employs education for marketing. Volume 21 of Issue 4. 2012. PMID: 22467711


  186. Kennedy A, Sullivan S, Hendlin Y, Barnes R, Glantz S. Strong tobacco control program requirements and secure funding are not enough: lessons from Florida. Volume 102 of Issue 5. American journal of public health 2012. PMID: 22420813


  187. Glantz SA. Pinocchio shows how to end the tobacco epidemic. Volume 21 of Issue 2. 2012. PMID: 22345273


  188. Lee S, Ling PM, Glantz SA. The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries. Volume 23 Suppl 1. 2012. PMID: 22370696


  189. Sebrié EM, Sandoya E, Hyland A, Bianco E, Glantz SA, Cummings KM. Hospital admissions for acute myocardial infarction before and after implementation of a comprehensive smoke-free policy in Uruguay. Volume 22 of Issue e1. 2012. PMID: 22337557


  190. Glantz SA, Iaccopucci A, Titus K, Polansky JR. Smoking in top-grossing US movies, 2011. Volume 9. 2012. PMID: 23017248


  191. Crosbie E, Sebrié EM, Glantz SA. Tobacco industry success in Costa Rica: the importance of FCTC article 5.3. Volume 54 of Issue 1. 2012. PMID: 22286826


  193. Gonzalez M, Ling PM, Glantz SA. Planting trees without leaving home: tobacco company direct-to-consumer CSR efforts. Volume 21 of Issue 3. 2011. PMID: 22193045


  194. Wertz MS, Kyriss T, Paranjape S, Glantz SA. The toxic effects of cigarette additives. Philip Morris' project mix reconsidered: an analysis of documents released through litigation. Volume 8 of Issue 12. PLoS medicine 2011. PMID: 22205885


  195. Millett C, Hanewinkel R, Britton J, Florek E, Faggiano F, Ness A, McKee M, Polansky JR, Glantz SA. European governments should stop subsidizing films with tobacco imagery. Volume 22 of Issue 2. 2011. PMID: 22179095


  196. Arnott D, Berteletti F, Britton J, Cardone A, Clancy L, Craig L, Fong GT, Glantz SA, Joossens L, Rudolphie MT, Rutgers MR, Smith SC, Stam H, West R, Willemsen MC. Can the Dutch Government really be abandoning smokers to their fate? Volume 379 of Issue 9811. Lancet (London, England) 2011. PMID: 22169107


  197. Gonzalez M, Glantz SA. Failure of policy regarding smoke-free bars in the Netherlands. Volume 23 of Issue 1. 2011. PMID: 22143826


  198. Cheng KW, Glantz SA, Lightwood JM. Association between smokefree laws and voluntary smokefree-home rules. Volume 41 of Issue 6. 2011. PMID: 22099232


  199. Weeks SG, Glantz SA, De Marco T, Rosen AB, Fleischmann KE. Secondhand smoke exposure and quality of life in patients with heart failure. Volume 171 of Issue 21. Archives of internal medicine 2011. PMID: 22123794


  200. Prochaska JJ, Benowitz NL, Glantz SA, Hudmon KS, Grossman W. Cardiology Rx for Change: improving clinical attention to tobacco use and secondhand smoke exposure in cardiology. Volume 34 of Issue 12. 2011. PMID: 21987417


  201. Basu S, Stuckler D, Bitton A, Glantz SA. Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis. Volume 343. BMJ (Clinical research ed.) 2011. PMID: 21972295


  202. Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Volume 379 of Issue 9822. Lancet (London, England) 2011. PMID: 21963004


  203. Glantz SA, Polansky JR. Movies with smoking make less money. Volume 21 of Issue 6. 2011. PMID: 21948805


  204. Mamudu HM, Gonzalez M, Glantz S. The nature, scope, and development of the global tobacco control epistemic community. Volume 101 of Issue 11. American journal of public health 2011. PMID: 21940926


  205. Millett C, Polansky JR, Glantz SA. Government inaction on ratings and government subsidies to the US film industry help promote youth smoking. Volume 8 of Issue 8. PLoS medicine 2011. PMID: 21886486


  206. Lee JT, Glantz SA, Millett C. Effect of smoke-free legislation on adult smoking behaviour in England in the 18 months following implementation. Volume 6 of Issue 6. PloS one 2011. PMID: 21698295


  207. Grana RA, Glantz SA, Ling PM. Electronic nicotine delivery systems in the hands of Hollywood. Volume 20 of Issue 6. 2011. PMID: 21659450


  209. Salgado MV, Glantz SA. Direct disease-inducing effects of menthol through the eyes of tobacco companies. Volume 20 Suppl 2. 2011. PMID: 21504931


  210. Lee YO, Glantz SA. Menthol: putting the pieces together. Volume 20 Suppl 2. 2011. PMID: 21504926


  212. Millett C, Lee JT, Gibbons DC, Glantz SA. Increasing the age for the legal purchase of tobacco in England: impacts on socio-economic disparities in youth smoking. Volume 66 of Issue 10. 2011. PMID: 21502102


  213. Glantz SA, Ling PM. Misleading conclusions from Altria researchers about population health effects of dual use. Volume 13 of Issue 4. 2011. PMID: 21350043


  214. Chu A, Jiang N, Glantz SA. Transnational tobacco industry promotion of the cigarette gifting custom in China. Volume 20 of Issue 4. 2011. PMID: 21282136


  215. Lightwood J, Glantz S. Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Volume 72 of Issue 2. Social science & medicine (1982) 2010. PMID: 21168248


  216. Crosbie E, Sebrié EM, Glantz SA. Strong advocacy led to successful implementation of smokefree Mexico City. Volume 20 of Issue 1. 2010. PMID: 21059606


  217. Gan Q, Glantz SA. Relationship between the Chinese tobacco industry and academic institutions in China. Volume 20 of Issue 1. 2010. PMID: 20952560


  218. Mamudu HM, Hammond R, Glantz SA. International trade versus public health during the FCTC negotiations, 1999-2003. Volume 20 of Issue 1. 2010. PMID: 20943828


  219. Sullivan S, Glantz SA. Local smoke-free ordinances are passing in tobacco-growing states. Volume 100 of Issue 11. American journal of public health 2010. PMID: 20864731


  220. Sullivan S, Glantz S. The changing role of agriculture in tobacco control policymaking: a South Carolina case study. Volume 71 of Issue 8. Social science & medicine (1982) 2010. PMID: 20828907


  221. Heiss C, Jahn S, Taylor M, Real WM, Angeli FS, Wong ML, Amabile N, Prasad M, Rassaf T, Ottaviani JI, Mihardja S, Keen CL, Springer ML, Boyle A, Grossman W, Glantz SA, Schroeter H, Yeghiazarians Y. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. Volume 56 of Issue 3. Journal of the American College of Cardiology 2010. PMID: 20620742


  223. Mejia AB, Ling PM, Glantz SA. Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA. Volume 19 of Issue 4. 2010. PMID: 20581427


  224. Hendlin Y, Anderson SJ, Glantz SA. 'Acceptable rebellion': marketing hipster aesthetics to sell Camel cigarettes in the US. Volume 19 of Issue 3. 2010. PMID: 20501494


  225. Gan Q, Lu W, Xu J, Li X, Goniewicz M, Benowitz NL, Glantz SA. Chinese 'low-tar' cigarettes do not deliver lower levels of nicotine and carcinogens. Volume 19 of Issue 5. 2010. PMID: 20507920


  226. Millett C, Glantz SA. Assigning an '18' rating to movies with tobacco imagery is essential to reduce youth smoking. Volume 65 of Issue 5. 2010. PMID: 20435857


  227. Cataldo JK, Glantz SA. Smoking cessation and Alzheimer's disease: facts, fallacies and promise. Volume 10 of Issue 5. Expert review of neurotherapeutics 2010. PMID: 20420482


  228. Schane RE, Ling PM, Glantz SA. Health effects of light and intermittent smoking: a review. Volume 121 of Issue 13. Circulation 2010. PMID: 20368531


  229. Shmueli D, Prochaska JJ, Glantz SA. Effect of smoking scenes in films on immediate smoking: a randomized controlled study. Volume 38 of Issue 4. 2010. PMID: 20307802


  230. Anderson SJ, Millett C, Polansky JR, Glantz SA. Exposure to smoking in movies among British adolescents 2001-2006. Volume 19 of Issue 3. 2010. PMID: 20197360


  231. Stanton CR, Chu A, Collin J, Glantz SA. Promoting tobacco through the international language of dance music: British American Tobacco and the Ministry of Sound. Volume 21 of Issue 1. 2010. PMID: 20159772


  232. Sebrié EM, Blanco A, Glantz SA. Cigarette labeling policies in Latin America and the Caribbean: progress and obstacles. Volume 52 Suppl 2. 2010. PMID: 21243194


  233. Cataldo JK, Prochaska JJ, Glantz SA. Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation. Volume 19 of Issue 2. 2010. PMID: 20110594


  234. Sebrié EM, Glantz SA. Local smoke-free policy development in Santa Fe, Argentina. Volume 19 of Issue 2. 2009. PMID: 19955534


  235. Gan Q, Yang J, Yang G, Goniewicz M, Benowitz NL, Glantz SA. Chinese "herbal" cigarettes are as carcinogenic and addictive as regular cigarettes. Volume 18 of Issue 12. 2009. PMID: 19959701


  236. Schane RE, Glantz SA, Ling PM. Nondaily and social smoking: an increasingly prevalent pattern. Volume 169 of Issue 19. Archives of internal medicine 2009. PMID: 19858429


  237. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Volume 120 of Issue 14. Circulation 2009. PMID: 19770392


  238. Otañez MG, Mamudu HM, Glantz SA. Tobacco companies' use of developing countries' economic reliance on tobacco to lobby against global tobacco control: the case of Malawi. Volume 99 of Issue 10. American journal of public health 2009. PMID: 19696392


  239. Schane RE, Glantz SA, Ling PM. Social smoking implications for public health, clinical practice, and intervention research. Volume 37 of Issue 2. 2009. PMID: 19589449


  240. Glantz SA, Barnes R, Eubanks SY. Compromise or capitulation? US Food and Drug Administration jurisdiction over tobacco products. Volume 6 of Issue 7. PLoS medicine 2009. PMID: 19636359


  241. Song AV, Glantz SA, Halpern-Felsher BL. Perceptions of second-hand smoke risks predict future adolescent smoking initiation. Volume 45 of Issue 6. 2009. PMID: 19931835


  243. Angeli FS, Shapiro M, Amabile N, Orcino G, Smith CS, Tacy T, Boyle AJ, Chatterjee K, Glantz SA, Grossman W, Yeghiazarians Y. Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy. Volume 59 of Issue 3. 2009. PMID: 19619418


  246. Dinno A, Glantz S. Tobacco control policies are egalitarian: a vulnerabilities perspective on clean indoor air laws, cigarette prices, and tobacco use disparities. Volume 68 of Issue 8. Social science & medicine (1982) 2009. PMID: 19282078


  247. Ling PM, Neilands TB, Glantz SA. Young adult smoking behavior: a national survey. Volume 36 of Issue 5. 2009. PMID: 19269128


  248. Tung GJ, Hendlin YH, Glantz SA. Competing initiatives: a new tobacco industry strategy to oppose statewide clean indoor air ballot measures. Volume 99 of Issue 3. American journal of public health 2009. PMID: 19150904


  249. Mamudu HM, Glantz SA. Civil society and the negotiation of the Framework Convention on Tobacco Control. Global public health 2009. PMID: 19333806


  250. Landman A, Glantz SA. Tobacco industry efforts to undermine policy-relevant research. Volume 99 of Issue 1. American journal of public health 2008. PMID: 19008508


  251. Mamudu HM, Hammond R, Glantz S. Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control. Volume 67 of Issue 11. Social science & medicine (1982) 2008. PMID: 18950924


  252. Schane RE, Glantz SA. Education on the dangers of passive smoking: a cessation strategy past due. Volume 118 of Issue 15. Circulation 2008. PMID: 18838572


  254. Lum KL, Polansky JR, Jackler RK, Glantz SA. Signed, sealed and delivered: "big tobacco" in Hollywood, 1927-1951. Tobacco control 2008. PMID: 18818225


  255. Lightwood JM, Dinno A, Glantz SA. Effect of the California tobacco control program on personal health care expenditures. Volume 5 of Issue 8. PLoS medicine 2008. PMID: 18752344


  257. Mamudu HM, Hammond R, Glantz SA. Project Cerberus: tobacco industry strategy to create an alternative to the Framework Convention on Tobacco Control. Volume 98 of Issue 9. American journal of public health 2008. PMID: 18633079


  259. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D, Wong ML, Jahn S, Angeli FS, Minasi P, Springer ML, Hammond SK, Glantz SA, Grossman W, Balmes JR, Yeghiazarians Y. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. Volume 51 of Issue 18. Journal of the American College of Cardiology 2008. PMID: 18452782


  260. Alamar BC, Glantz SA. Externalities in the Workplace: A Response to a Rejoinder to a Response to a Response to a Paper. Volume 5 of Issue 2. 2008. PMID: 19756237


  261. Slinker BK, Glantz SA. Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable. Volume 117 of Issue 13. Circulation 2008. PMID: 18378626


  262. Landman A, Cortese DK, Glantz S. Tobacco industry sociological programs to influence public beliefs about smoking. Volume 66 of Issue 4. Social science & medicine (1982) 2008. PMID: 18164524


  263. Sebrié EM, Schoj V, Glantz SA. Smokefree environments in Latin America: on the road to real change? Volume 3 of Issue 1. 2008. PMID: 19578527


  264. Johnson KC, Glantz SA. Evidence secondhand smoke causes breast cancer in 2005 stronger than for lung cancer in 1986. Preventive medicine 2007. PMID: 18182169


  265. Song AV, Ling PM, Neilands TB, Glantz SA. Smoking in movies and increased smoking among young adults. Volume 33 of Issue 5. 2007. PMID: 17950405


  266. Tong EK, Glantz SA. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Volume 116 of Issue 16. Circulation 2007. PMID: 17938301


  267. Sebrié EM, Glantz SA. "Accommodating" smoke-free policies: tobacco industry's Courtesy of Choice programme in Latin America. Volume 16 of Issue 5. 2007. PMID: 17897975


  268. Barnes RL, Glantz SA. Endotoxins in tobacco smoke: shifting tobacco industry positions. Volume 9 of Issue 10. 2007. PMID: 17852769


  270. Otañez MG, Mamudu H, Glantz SA. Global leaf companies control the tobacco market in Malawi. Volume 16 of Issue 4. 2007. PMID: 17652242


  271. Anderson SJ, Ling PM, Glantz SA. Implications of the federal court order banning the terms "light" and "mild": what difference could it make? Volume 16 of Issue 4. 2007. PMID: 17652244


  272. Sebrié EM, Glantz SA. Attempts to undermine tobacco control: tobacco industry "youth smoking prevention" programs to undermine meaningful tobacco control in Latin America. Volume 97 of Issue 8. American journal of public health 2007. PMID: 17600260


  273. Alamar B, Glantz SA. Effect of smoke-free laws on bar value and profits. Volume 97 of Issue 8. American journal of public health 2007. PMID: 17600258


  274. Ling PM, Neilands TB, Glantz SA. The effect of support for action against the tobacco industry on smoking among young adults. Volume 97 of Issue 8. American journal of public health 2007. PMID: 17600255


  275. Ibrahim JK, Glantz SA. The rise and fall of tobacco control media campaigns, 1967 2006. Volume 97 of Issue 8. American journal of public health 2007. PMID: 17600257


  277. John RM, Glantz SA. It is time to make smokefree environments work in India. Volume 125 of Issue 5. 2007. PMID: 17642492


  278. Dinno A, Glantz S. Clean indoor air laws immediately reduce heart attacks. Volume 45 of Issue 1. 2007. PMID: 17499350


  279. Chen A, Glantz S, Tong E. Asian herbal-tobacco cigarettes: "not medicine but less harmful"? Volume 16 of Issue 2. 2007. PMID: 17400933


  281. Schick SF, Schick S, Glantz SA. Sidestream cigarette smoke toxicity increases with aging and exposure duration. Volume 15 of Issue 6. 2006. PMID: 17130369


  285. Healton CG, Watson-Stryker ES, Allen JA, Vallone DM, Messeri PA, Graham PR, Stewart AM, Dobbins MD, Glantz SA. Televised movie trailers: undermining restrictions on advertising tobacco to youth. Volume 160 of Issue 9. Archives of pediatrics & adolescent medicine 2006. PMID: 16953010


  286. Mandel LL, Bialous SA, Glantz SA. Avoiding "truth": tobacco industry promotion of life skills training. Volume 39 of Issue 6. 2006. PMID: 17116518


  287. Alamar B, Glantz SA. Effect of increased social unacceptability of cigarette smoking on reduction in cigarette consumption. Volume 96 of Issue 8. American journal of public health 2006. PMID: 16809588


  290. Alamar B, Glantz SA. Tobacco industry profits from smoking images in the movies. Volume 117 of Issue 4. Pediatrics 2006. PMID: 16585358


  291. Alamar B, Glantz SA. Modeling Addictive Consumption as an Infectious Disease. Volume 5 of Issue 1. 2006. PMID: 21339848


  292. Sebrié E, Glantz SA. The tobacco industry in developing countries. Volume 332 of Issue 7537. BMJ (Clinical research ed.) 2006. PMID: 16470028


  293. Glantz SA, Polansky J. Smoking in movies. Volume 129 of Issue 2. Chest 2006. PMID: 16478874


  294. Ibrahim JK, Glantz SA. Tobacco industry litigation strategies to oppose tobacco control media campaigns. Volume 15 of Issue 1. 2006. PMID: 16436406


  295. Charlesworth A, Glantz SA. Tobacco and the movie industry. Volume 5 of Issue 1. 2006. PMID: 16446255


  296. Glantz FK, Glantz SA. Protecting Europeans from secondhand smoke: time to act. Volume 27 of Issue 4. 2005. PMID: 16339159


  298. Charlesworth A, Glantz SA. Smoking in the movies increases adolescent smoking: a review. Volume 116 of Issue 6. Pediatrics 2005. PMID: 16322180


  299. Ling PM, Glantz SA. Tobacco industry consumer research on socially acceptable cigarettes. Tobacco control 2005. PMID: 16183968


  301. Sebrié EM, Barnoya J, Pérez-Stable EJ, Glantz SA. Tobacco industry successfully prevented tobacco control legislation in Argentina. Tobacco control 2005. PMID: 16183967


  302. Barnoya J, Glantz SA. The tobacco industry's worldwide ETS consultants project: European and Asian components. Volume 16 of Issue 1. 2005. PMID: 16076855


  303. Schick S, Glantz S. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972. Volume 7 of Issue 4. 2005. PMID: 16085530


  304. Barnoya J, Bialous SA, Glantz SA. Effective interventions to reduce smoking-induced heart disease around the world: time to act. Volume 112 of Issue 4. Circulation 2005. PMID: 16043657


  305. Cook DM, Tong EK, Glantz SA, Bero LA. The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke. Volume 24 of Issue 4. Health affairs (Project Hope) 2005. PMID: 16136637


  306. Ong MK, Glantz SA. Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison. Volume 95 of Issue 6. American journal of public health 2005. PMID: 15914818


  307. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Volume 111 of Issue 20. Circulation 2005. PMID: 15911719


  308. Glantz SA. Tobacco money at the University of California. Volume 171 of Issue 10. American journal of respiratory and critical care medicine 2005. PMID: 15879426


  309. Anderson SJ, Glantz SA, Ling PM. Emotions for sale: cigarette advertising and women's psychosocial needs. Tobacco control 2005. PMID: 15791023


  310. Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. Tobacco control 2005. PMID: 15791022


  311. Tong EK, England L, Glantz SA. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry. Volume 115 of Issue 3. Pediatrics 2005. PMID: 15741361


  312. Glantz SA, Mandel LL. Since school-based tobacco prevention programs do not work, what should we do? Volume 36 of Issue 3. 2005. PMID: 15737768


  313. Mandel LL, Alamar BC, Glantz SA. Smoke-free law did not affect revenue from gaming in Delaware. Tobacco control 2005. PMID: 15735294


  314. Bitton A, Neuman MD, Barnoya J, Glantz SA. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest. Volume 365 of Issue 9458. Lancet (London, England) 2005. PMID: 15705463


  315. S. Glantz. Primer of Biostatistics (6 ed) 2005. PMID:


  316. Kunyk D, Freeman B, Glantz S. Health conventions in smoke free places have positive economic impact. Volume 329 of Issue 7478. BMJ (Clinical research ed.) 2004. PMID: 15576760


  318. Lambert A, Sargent JD, Glantz SA, Ling PM. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control. Tobacco control 2004. PMID: 15564622


  319. Alamar BC, Glantz SA. SMOKE-FREE ORDINANCES INCREASE RESTAURANT PROFIT AND VALUE. Volume 22 of Issue 4. 2004. PMID: 21637722


  320. Barnoya J, Glantz S. Association of the California tobacco control program with declines in lung cancer incidence. Volume 15 of Issue 7. 2004. PMID: 15280627


  321. Mandel LL, Glantz SA. Hedging their bets: tobacco and gambling industries work against smoke-free policies. Tobacco control 2004. PMID: 15333883


  322. Ibrahim JK, Tsoukalas TH, Glantz SA. Public health foundations and the tobacco industry: lessons from Minnesota. Tobacco control 2004. PMID: 15333877


  323. Alamar BC, Glantz SA. The tobacco industry's use of Wall Street analysts in shaping policy. Tobacco control 2004. PMID: 15333876


  324. Ong MK, Glantz SA. Cardiovascular health and economic effects of smoke-free workplaces. Volume 117 of Issue 1. The American journal of medicine 2004. PMID: 15210386


  325. Barnoya J, Glantz SA. Modifiable behavioral factors as causes of death. Volume 291 of Issue 24. JAMA 2004. PMID: 15213199


  326. Ling PM, Glantz SA. Tobacco industry research on smoking cessation. Recapturing young adults and other recent quitters. Volume 19 of Issue 5 Pt 1. Journal of general internal medicine 2004. PMID: 15109339


  327. Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. Volume 328 of Issue 7446. BMJ (Clinical research ed.) 2004. PMID: 15066887


  328. Neilsen K, Glantz SA. A tobacco industry study of airline cabin air quality: dropping inconvenient findings. Tobacco control 2004. PMID: 14985613


  330. Nixon ML, Mahmoud L, Glantz SA. Tobacco industry litigation to deter local public health ordinances: the industry usually loses in court. Tobacco control 2004. PMID: 14985600


  331. Glantz SA, Kacirk KW, McCulloch C. Back to the future: Smoking in movies in 2002 compared with 1950 levels. Volume 94 of Issue 2. American journal of public health 2004. PMID: 14759939


  332. Barnoya J, Glantz S. Secondhand smoke and cardiologists: the missing link. Volume 93 of Issue 2-3. International journal of cardiology 2004. PMID: 14975576


  333. Barnoya J, Glantz SA. Secondhand smoke: the evidence of danger keeps growing. Volume 116 of Issue 3. The American journal of medicine 2004. PMID: 14749167


  334. Givel M, Glantz SA. The "global settlement" with the tobacco industry: 6 years later. Volume 94 of Issue 2. American journal of public health 2004. PMID: 14759930


  335. Glantz SA. Effect of viewing smoking in movies on adolescent smoking initiation: a cohor study. Volume 144 of Issue 1. The Journal of pediatrics 2004. PMID: 14735907


  338. Weber MD, Bagwell DA, Fielding JE, Glantz SA. Long term compliance with California's Smoke-Free Workplace Law among bars and restaurants in Los Angeles County. Tobacco control 2003. PMID: 12958386


  339. Zhu BQ, Heeschen C, Sievers RE, Karliner JS, Parmley WW, Glantz SA, Cooke JP. Second hand smoke stimulates tumor angiogenesis and growth. Volume 4 of Issue 3. 2003. PMID: 14522253


  340. Tsoukalas T, Glantz SA. The Duluth clean indoor air ordinance: problems and success in fighting the tobacco industry at the local level in the 21st century. Volume 93 of Issue 8. American journal of public health 2003. PMID: 12893598


  341. Glantz SA. Smoking in movies: a major problem and a real solution. Volume 362 of Issue 9380. Lancet (London, England) 2003. PMID: 12892950


  342. Tsoukalas TH, Glantz SA. Development and destruction of the first state funded anti-smoking campaign in the USA. Tobacco control 2003. PMID: 12773734


  343. Scollo M, Lal A, Hyland A, Glantz S. Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry. Tobacco control 2003. PMID: 12612356


  344. Barnoya J, Glantz SA. The tobacco industry and secondhand smoke: lessons from Central and South America. Volume 13 of Issue 2 Suppl 2. 2003. PMID: 13677420


  345. Bialous SA, Glantz SA. ASHRAE Standard 62: tobacco industry's influence over national ventilation standards. Tobacco control 2002. PMID: 12432157


  347. Barnoya J, Glantz S. Knowledge and use of tobacco among Guatemalan physicians. Volume 13 of Issue 9. 2002. PMID: 12462553


  348. Glantz SA. Limiting youth access to tobacco: a failed intervention. Volume 31 of Issue 4. 2002. PMID: 12359373


  349. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. Volume 325 of Issue 7357. BMJ (Clinical research ed.) 2002. PMID: 12142305


  350. Ling PM, Glantz SA. Using tobacco-industry marketing research to design more effective tobacco-control campaigns. Volume 287 of Issue 22. JAMA 2002. PMID: 12052128


  351. Ling PM, Glantz SA. Nicotine addiction, young adults, and smoke-free bars. Volume 21 of Issue 2. 2002. PMID: 12188987


  352. Dearlove JV, Bialous SA, Glantz SA. Tobacco industry manipulation of the hospitality industry to maintain smoking in public places. Tobacco control 2002. PMID: 12034999


  353. Landman A, Ling PM, Glantz SA. Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control. Volume 92 of Issue 6. American journal of public health 2002. PMID: 12036777


  354. Ling PM, Glantz SA. Why and how the tobacco industry sells cigarettes to young adults: evidence from industry documents. Volume 92 of Issue 6. American journal of public health 2002. PMID: 12036776


  355. Fichtenberg CM, Glantz SA. Youth access interventions do not affect youth smoking. Volume 109 of Issue 6. Pediatrics 2002. PMID: 12042547


  356. Neuman M, Bitton A, Glantz S. Tobacco industry strategies for influencing European Community tobacco advertising legislation. Volume 359 of Issue 9314. Lancet (London, England) 2002. PMID: 11965294


  357. Glantz SA. Air pollution as a cause of heart disease. Time for action. Volume 39 of Issue 6. Journal of the American College of Cardiology 2002. PMID: 11897433


  358. Mekemson C, Glantz SA. How the tobacco industry built its relationship with Hollywood. Tobacco control 2002. PMID: 11893818


  359. Ling PM, Landman A, Glantz SA. It is time to abandon youth access tobacco programmes. Tobacco control 2002. PMID: 11891349


  360. Sepe E, Ling PM, Glantz SA. Smooth moves: bar and nightclub tobacco promotions that target young adults. Volume 92 of Issue 3. American journal of public health 2002. PMID: 11867322


  361. Zhu BQ, Sievers RE, Browne AE, Hillman RT, Chair K, Lee RJ, Chatterjee K, Glantz SA, Parmley WW. The renin-angiotensin system does not contribute to the endothelial dysfunction and increased infarct size in rats exposed to second hand smoke. Volume 3 of Issue 1. 2002. PMID: 11984749


  362. Dearlove JV, Glantz SA. Boards of Health as venues for clean indoor air policy making. Volume 92 of Issue 2. American journal of public health 2002. PMID: 11818302


  363. Givel MS, Glantz SA. State tobacco settlement funds not being spent on vigorous tobacco control efforts. Volume 16 of Issue 2. 2002. PMID: 11866133


  364. Sepe E, Glantz SA. Bar and club tobacco promotions in the alternative press: targeting young adults. Volume 92 of Issue 1. American journal of public health 2002. PMID: 11772765


  365. Glantz SA. Rate movies with smoking "R". Volume 5 of Issue 1. Effective clinical practice : ECP 2002. PMID: 11874194


  366. Glantz SA. Smoking in teenagers and watching films showing smoking. BMJ (Clinical research ed.) 2001. PMID: 11744548


  367. Bitton A, Fichtenberg C, Glantz S. msJAMA: reducing smoking prevalence to 10% in five years. JAMA 2001. PMID: 11730453


  368. Kacirk K, Glantz SA. Smoking in movies in 2000 exceeded rates in the 1960s. Tobacco control 2001. PMID: 11806354


  369. Ong EK, Glantz SA. Constructing "sound science" and "good epidemiology": tobacco, lawyers, and public relations firms. American journal of public health 2001. PMID: 11684593


  370. Sun YP, Zhu BQ, Browne AE, Sievers RE, Bekker JM, Chatterjee K, Parmley WW, Glantz SA. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation 2001. PMID: 11502707


  371. Glantz SA, Parmley WW. Even a little secondhand smoke is dangerous. JAMA 2001. PMID: 11466127


  372. Magzamen S, Charlesworth A, Glantz SA. Print media coverage of California's smokefree bar law. Tobacco control 2001. PMID: 11387536


  373. Givel MS, Glantz SA. Tobacco lobby political influence on US state legislatures in the 1990s. Tobacco control 2001. PMID: 11387532


  374. Lightwood J, Fleischmann KE, Glantz SA. Smoking cessation in heart failure: it is never too late. Journal of the American College of Cardiology 2001. PMID: 11345384


  375. Sun YP, Zhu BQ, Browne AE, Pulukurthy S, Chou TM, Sudhir K, Glantz SA, Deedwania PC, Chatterjee K, Parmley WW. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. Journal of cardiovascular pharmacology and therapeutics 2001. PMID: 11509924


  376. Magzamen S, Glantz SA. The new battleground: California's experience with smoke-free bars. American journal of public health 2001. PMID: 11211633


  377. Bialous SA, Fox BJ, Glantz SA. Tobacco industry allegations of "illegal lobbying" and state tobacco control. American journal of public health 2001. PMID: 11189827


  378. Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. The New England journal of medicine 2000. PMID: 11114317


  379. Glantz SA, Jamieson P. Attitudes toward secondhand smoke, smoking, and quitting among young people. Pediatrics 2000. PMID: 11099625


  380. Glantz SA, Parmely WW. Does secondhand smoke activate platelets? Toxicological sciences : an official journal of the Society of Toxicology 2000. PMID: 11099652


  381. Glantz SA. Lung cancer and passive smoking. Nothing new was said. BMJ (Clinical research ed.) 2000. PMID: 11073523


  382. Glantz SA. The truth about big tobacco in its own words. BMJ (Clinical research ed.) 2000. PMID: 10926570


  383. Balbach ED, Traynor MP, Glantz SA. The implementation of California's tobacco tax initiative: the critical role of outsider strategies in protecting Proposition 99. Journal of health politics, policy and law 2000. PMID: 10979517


  384. Glantz SA. Compete with the tobacco industry. Tobacco control 2000. PMID: 10841865


  385. Barbier P, Solomon S, Schiller NB, Glantz SA. Determinants of forward pulmonary vein flow: an open pericardium pig model. Journal of the American College of Cardiology 2000. PMID: 10841248


  386. Laugesen M, Scollo M, Sweanor D, Shiffman S, Gitchell J, Barnsley K, Jacobs M, Giovino GA, Glantz SA, Daynard RA, Connolly GN, Difranza JR. World's best practice in tobacco control. Tobacco control 2000. PMID: 10841861


  387. Givel MS, Glantz SA. Failure to defend a successful state tobacco control program: policy lessons from Florida. American journal of public health 2000. PMID: 10800426


  389. Glantz SA. Effect of smokefree bar law on bar revenues in California. Tobacco control 2000. PMID: 10798865


  390. Glantz S, Glantz JC, Campbell-Heider N, Schaff E. Norplant use among urban minority women in the United States. Contraception 2000. PMID: 10802272


  391. Ong E, Glantz SA. Hirayama's work has stood the test of time. Bulletin of the World Health Organization 2000. PMID: 10994268


  393. Glantz S. Stan Glantz, tobacco warrior. Bulletin of the World Health Organization 2000. PMID: 10994274


  394. S. Glantz, E. Balbach. Tobacco War: Inside the California Battles 2000. PMID:


  395. Givel MS, Glantz SA. Tobacco control and direct democracy in Dade County, Florida: future implications for health advocates. Journal of public health policy 2000. PMID: 11021043


  396. Glantz SA. Tobacco related disease research program. Tobacco control 2000. PMID: 10841584


  397. Lightwood JM, Phibbs CS, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics 1999. PMID: 10585982


  398. Barbier P, Solomon SB, Schiller NB, Glantz SA. Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. Circulation 1999. PMID: 10421605


  399. Hutchison SJ, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Cooke JP, Glantz SA, Parmley WW. Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke. Hypertension (Dallas, Tex. : 1979) 1999. PMID: 10406822


  400. Solomon SB, Glantz SA. Regional ischemia increases sensitivity of left ventricular relaxation to volume in pigs. The American journal of physiology 1999. PMID: 10362680


  402. Glantz SA. [The leading role of Norway in tobacco use prevention must be regained]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 1999. PMID: 10210962


  403. Solomon SB, Barbier P, Glantz SA. Changes in porcine transmitral flow velocity pattern and its diastolic determinants during partial coronary occlusion. Journal of the American College of Cardiology 1999. PMID: 10080491


  405. Glantz SA. Smoke-free restaurant ordinances do not affect restaurant business. Period. Journal of public health management and practice : JPHMP 1999. PMID: 10345506


  406. Goldman LK, Glantz SA. The passage and initial implementation of Oregon's Measure 44. Tobacco control 1999. PMID: 10599577


  407. Hutchison SJ, Glantz SA, Zhu BQ, Sun YP, Chou TM, Chatterjee K, Deedwania PC, Parmley WW, Sudhir K. In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. Journal of the American College of Cardiology 1998. PMID: 9809964


  408. Monardi F, Glantz SA. Are tobacco industry campaign contributions influencing state legislative behavior? American journal of public health 1998. PMID: 9618620


  409. Tayama M, Solomon SB, Glantz SA. Effect of lidocaine on left ventricular pressure-volume curves during demand ischemia in pigs. The American journal of physiology 1998. PMID: 9841537


  410. Schwarzacher SP, Hutchison S, Chou TM, Sun YP, Zhu BQ, Chatterjee K, Glantz SA, Deedwania PC, Parmley WW, Sudhir K. Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke. Journal of cardiovascular pharmacology 1998. PMID: 9593062


  411. Goldman LK, Glantz SA. Evaluation of antismoking advertising campaigns. JAMA 1998. PMID: 9508154


  412. Solomon SB, Nikolic SD, Glantz SA, Yellin EL. Left ventricular diastolic function of remodeled myocardium in dogs with pacing-induced heart failure. The American journal of physiology 1998. PMID: 9530208


  413. Teti TS, Glantz SA. Smoking in movies remained high in 1997. Tobacco control 1998. PMID: 10093182


  415. Zhu BQ, Sun YP, Sudhir K, Sievers RE, Browne AE, Gao L, Hutchison SJ, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW. Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period. Journal of the American College of Cardiology 1997. PMID: 9385922


  416. Macdonald H, Aguinaga S, Glantz SA. The defeat of Philip Morris' 'California Uniform Tobacco Control Act'. American journal of public health 1997. PMID: 9431289


  417. Glantz SA, Smith LR. The effect of ordinances requiring smoke-free restaurants and bars on revenues: a follow-up. American journal of public health 1997. PMID: 9357356


  419. Hutchison SJ, Reitz MS, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW. Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits. Hypertension (Dallas, Tex. : 1979) 1997. PMID: 9149685


  420. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. Journal of the American College of Cardiology 1997. PMID: 9091527


  421. Glantz SA, Fox BJ, Lightwood JM. Tobacco litigation. Issues for public health and public policy. JAMA 1997. PMID: 9042849


  422. Glantz SA. After ASSIST, what next? SCIENCE. Tobacco control 1997. PMID: 9583633


  423. Glantz SA. Back to basics: getting smoke-free workplaces back on track. Tobacco control 1997. PMID: 9396094


  425. Begay ME, Glantz SA. Question 1 tobacco education expenditures in Massachusetts, USA. Tobacco control 1997. PMID: 9396106


  426. Stockwell TF, Glantz SA. Tobacco use is increasing in popular films. Tobacco control 1997. PMID: 9583625


  427. Glantz SA. The ledger of tobacco control. JAMA 1996. PMID: 8782631


  428. Glantz SA, Parmley WW. Passive and active smoking. A problem for adults. Circulation 1996. PMID: 8772672


  429. Zhu B, Sun Y, Sievers RE, Shuman JL, Glantz SA, Chatterjee K, Parmley WW, Wolfe CL. L-arginine decreases infarct size in rats exposed to environmental tobacco smoke. American heart journal 1996. PMID: 8701882


  430. Smedberg JI, Nilner K, Rangert B, Svensson SA, Glantz SA. On the influence of superstructure connection on implant preload: a methodological and clinical study. Clinical oral implants research 1996. PMID: 9002823


  431. Glantz SA. Preventing tobacco use--the youth access trap. American journal of public health 1996. PMID: 8633727


  432. Traynor MP, Glantz SA. California's tobacco tax initiative: the development and passage of Proposition 99. Journal of health politics, policy and law 1996. PMID: 8784688


  433. Glantz S. Stanton Glantz on snuffing tobacco research. Interview by Thomasine Kushner. Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees 1996. PMID: 8862828


  434. S. Glantz, J. Slade, L. Bero, P. Hanauer, D. Barnes. The Cigarette Papers 1996. PMID:


  435. Balbach ED, Glantz SA. Tobacco information in two grade school newsweeklies: a content analysis. American journal of public health 1995. PMID: 7503339


  436. Cardador MT, Hazan AR, Glantz SA. Tobacco industry smokers' rights publications: a content analysis. American journal of public health 1995. PMID: 7661227


  437. Glantz SA. Tobacco, history, and the AMA. Lancet (London, England) 1995. PMID: 7637509


  438. Barnes DE, Hanauer P, Slade J, Bero LA, Glantz SA. Environmental tobacco smoke. The Brown and Williamson documents. JAMA 1995. PMID: 7609234


  440. Bero L, Barnes DE, Hanauer P, Slade J, Glantz SA. Lawyer control of the tobacco industry's external research program. The Brown and Williamson documents. JAMA 1995. PMID: 7609233


  441. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA 1995. PMID: 7609230


  442. Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA. Nicotine and addiction. The Brown and Williamson documents. JAMA 1995. PMID: 7609231


  443. Glantz S, Schaff E, Campbell-Heider N, Glantz JC, Bartlett M. Contraceptive implant use among inner city teens. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 1995. PMID: 7662690


  445. Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA 1995. PMID: 7897790


  447. Hazan AR, Glantz SA. Current trends in tobacco use on prime-time fictional television. American journal of public health 1995. PMID: 7832246


  449. Glantz SA, Bero LA. Inappropriate and appropriate selection of 'peers' in grant review. JAMA 1994. PMID: 8015118


  450. Bero LA, Glantz SA, Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA 1994. PMID: 8015124


  451. Glantz SA, Smith LR. The effect of ordinances requiring smoke-free restaurants on restaurant sales. American journal of public health 1994. PMID: 8017529


  452. Hazan AR, Lipton HL, Glantz SA. Popular films do not reflect current tobacco use. American journal of public health 1994. PMID: 8203700


  453. Sun YP, Zhu BQ, Sievers RE, Glantz SA, Parmley WW. Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation 1994. PMID: 8181151


  454. Shintani H, Glantz SA. Influence of filling on left ventricular diastolic pressure-volume curve during pacing ischemia in dogs. The American journal of physiology 1994. PMID: 8184915


  455. Glantz SA. Actual causes of death in the United States. JAMA 1994. PMID: 8309022


  456. Zhu BQ, Sun YP, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation 1994. PMID: 8124817


  457. Becker DM, Windsor R, Ockene JK, Berman B, Best JA, Cummings KM, Glantz S, Haynes S, Henningfield J, Novotny TE. Setting the policy, education, and research agenda to reduce tobacco use. Workshop I. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health. Circulation 1993. PMID: 8353904


  458. Begay ME, Traynor M, Glantz SA. The tobacco industry, state politics, and tobacco education in California. American journal of public health 1993. PMID: 8362994


  459. Traynor MP, Begay ME, Glantz SA. New tobacco industry strategy to prevent local tobacco control. JAMA 1993. PMID: 8320788


  460. Nguyen TN, Chagas AC, Glantz SA. Left ventricular adaptation to gradual renovascular hypertension in dogs. The American journal of physiology 1993. PMID: 8102034


  461. Woodruff TJ, Rosbrook B, Pierce J, Glantz SA. Lower levels of cigarette consumption found in smoke-free workplaces in California. Archives of internal medicine 1993. PMID: 8512439


  462. Shintani H, Glantz SA. Effect of disrupting the mitral apparatus on left ventricular function in dogs. Circulation 1993. PMID: 8504515


  463. Glantz SA. Heart disease and the environment. Journal of the American College of Cardiology 1993. PMID: 8473658


  465. Glantz SA. It is all in the numbers. Journal of the American College of Cardiology 1993. PMID: 8436765


  466. Glantz SA. Removing the incentive to sell kids tobacco. A proposal. JAMA 1993. PMID: 8423664


  467. Nguyen TN, Glantz SA. Floating axis does not reduce motion artifacts in a model of left ventricular wall motion in dogs. The American journal of physiology 1993. PMID: 8447475


  468. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. Journal of the American College of Cardiology 1993. PMID: 8417066


  469. Glantz SA, Parmley WW. Passive smoking causes heart disease and lung cancer. Journal of clinical epidemiology 1992. PMID: 1624962


  470. Samuels BE, Begay ME, Hazan AR, Glantz SA. Philip Morris's failed experiment in Pittsburgh. Journal of health politics, policy and law 1992. PMID: 1500653


  471. Samuels B, Glantz SA. The politics of local tobacco control. JAMA 1991. PMID: 1920699


  472. Ohtani M, Nikolic SD, Glantz SA. A new approach to in situ left ventricular volume clamping in dogs. The American journal of physiology 1991. PMID: 1928415


  473. Glantz SA, Parmley WW. Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation 1991. PMID: 1984876


  474. Appleyard RF, Glantz SA. Pulmonary model to predict the effects of series ventricular interaction. Circulation research 1990. PMID: 2225356


  475. Glantz SA. A method to estimate the point at which two lines intersect from noisy data. The American journal of physiology 1990. PMID: 2221134


  476. Stillman FA, Becker DM, Swank RT, Hantula D, Moses H, Glantz S, Waranch HR. Ending smoking at the Johns Hopkins Medical Institutions. An evaluation of smoking prevalence and indoor air pollution. JAMA 1990. PMID: 2395198


  477. Glantz SA, Boltwood CM, Appleyard RF, Applegate RJ, Cheng CP, Little WC. Volume conductance catheter. Circulation 1990. PMID: 2344690


  478. Slinker BK, Glantz SA. Missing data in two-way analysis of variance. The American journal of physiology 1990. PMID: 2137989


  479. Appleyard RF, Glantz SA. Two dimensions describe left ventricular volume change during hemodynamic transients. The American journal of physiology 1990. PMID: 2301611


  481. Glantz SA. Financial impact of animal regulation. Science (New York, N.Y.) 1989. PMID: 2740895


  482. Gilbert JC, Glantz SA. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circulation research 1989. PMID: 2523260


  483. Slinker BK, Glantz SA. Beat-to-beat regulation of left ventricular function in the intact cardiovascular system. The American journal of physiology 1989. PMID: 2705583


  484. Glantz SA, Stromberg D. Public attitudes regarding smokefree airlines. American journal of public health 1988. PMID: 3421400


  485. Slinker BK, Glantz SA. Multiple linear regression is a useful alternative to traditional analyses of variance. The American journal of physiology 1988. PMID: 3046375


  486. Chagas AC, Glantz SA. Angiographic validation of eigenvolume to measure left ventricular size. Circulation research 1988. PMID: 3383367


  487. Glantz SA. Achieving a smokefree society. Circulation 1987. PMID: 3652418


  488. Slinker BK, Chagas AC, Glantz SA. Chronic pressure overload hypertrophy decreases direct ventricular interaction. The American journal of physiology 1987. PMID: 2956897


  489. Glantz SA. Passive smoking. The New Zealand medical journal 1987. PMID: 3452055


  490. Florenzano F, Glantz SA. Left ventricular mechanical adaptation to chronic aortic regurgitation in intact dogs. The American journal of physiology 1987. PMID: 2953255


  491. Glantz SA. Passive smoking. The New Zealand medical journal 1987. PMID: 3469557


  492. Tye JB, Warner KE, Glantz SA. Tobacco advertising and consumption: evidence of a causal relationship. Journal of public health policy 1987. PMID: 3323236


  493. Slinker BK, Glantz SA. End-systolic and end-diastolic ventricular interaction. The American journal of physiology 1986. PMID: 3777194


  494. Calvin JE, Baer RW, Glantz SA. Pulmonary injury depresses cardiac systolic function through Starling mechanism. The American journal of physiology 1986. PMID: 3766749


  495. Slinker BK, Glantz SA. Multiple regression for physiological data analysis: the problem of multicollinearity. The American journal of physiology 1985. PMID: 4014489


  496. Hannaford B, Glantz SA. Adaptive linear predictor tracks implanted radiopaque markers. IEEE transactions on bio-medical engineering 1985. PMID: 3997166


  499. Glantz SA. What to do because evidence links involuntary (passive) smoking with lung cancer. The Western journal of medicine 1984. PMID: 6719922


  500. Giammona M, Glantz SA. Poor statistical design in research on humans: the role of committees on human research. Clinical research 1983. PMID: 6667598


  501. Sacks ST, Glantz SA. Introduction to biostatistics. An annotated bibliography for medical researchers. The Western journal of medicine 1983. PMID: 6362205


  503. Linderer T, Chatterjee K, Parmley WW, Sievers RE, Glantz SA, Tyberg JV. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation 1983. PMID: 6831669


  504. Walley KR, Grover M, Raff GL, Benge JW, Hannaford B, Glantz SA. Left ventricular dynamic geometry in the intact and open chest dog. Circulation research 1982. PMID: 7067064


  505. Battagin RL, Glantz SA. Multiplexer displays two pressure signals on single oscilloscope channel. The American journal of physiology 1982. PMID: 7065162


  507. Davis PL, Raff GL, Glantz SA. A method to identify implanted radiopaque markers despite rotation of the heart. The American journal of physiology 1980. PMID: 7425149


  508. Wilkinson PL, Stowe DF, Glantz SA, Tyberg JV. Heart rate-systemic blood pressure relationship in dogs during halothane anesthesia. Acta anaesthesiologica Scandinavica 1980. PMID: 7445934


  509. Glantz SA. Computing indices of diastolic stiffness has been counterproductive. Federation proceedings 1980. PMID: 7353674


  511. Misbach GA, Glantz SA. Changes in the diastolic pressure-diameter relation after ventricular function curves. The American journal of physiology 1979. PMID: 517663


  512. Tyberg JV, Misbach GA, Glantz SA. Altered left ventricular diastolic properties. Circulation 1979. PMID: 445763


  513. Gelberg HJ, Brundage BH, Glantz S, Parmley WW. Quantitative left ventricular wall motion analysis: a comparison of area, chord and radial methods. Circulation 1979. PMID: 428111


  514. Glantz SA, Tyberg JV. Determination of frequency response from step response: application to fluid-filled catheters. The American journal of physiology 1979. PMID: 420321


  516. Tyberg JV, Misbach GA, Glantz SA, Moores WY, Parmley WW. A mechanism for shifts in the diastolic, left ventricular, pressure-volume curve: the role of the pericardium. European journal of cardiology 1978. PMID: 668760


  517. Stowe DF, Mathey DG, Moores WY, Glantz SA, Townsend RM, Kabra P, Chatterjee K, Parmley WW, Tyberg JV. Segment stroke work and metabolism depend on coronary blood flow in the pig. The American journal of physiology 1978. PMID: 645926


  518. Glantz SA, Misbach GA, Moores WY, Mathey DG, Lekven J, Stowe DF, Parmley WW, Tyberg JV. The pericardium substantially affects the left ventricular diastolic pressure-volume relationship in the dog. Circulation research 1978. PMID: 624151


  519. Glantz SA, Parmley WW. Factors which affect the diastolic pressure-volume curve. Circulation research 1978. PMID: 162735


  520. Misbach GA, Glantz SA, Tyberg JV, Moores WY. Improved compliance and ventricular function curves after open-heart surgery: role of the pericardium. Surgical forum 1978. PMID: 401150


  521. Glantz SA. A three-element description for muscle with viscoelastic passive elements. Journal of biomechanics 1977. PMID: 139410


  522. Parmley WW, Tyberg JV, Glantz SA. Cardiac dynamics. Annual review of physiology 1977. PMID: 322599


  523. Glantz SA. Ventricular pressure-volume curve indices change with end-diastolic pressure. Circulation research 1976. PMID: 1000770


  524. Alderman EL, Glantz SA. Acute hemodynamic interventions shift the diastolic pressure-volume curve in man. Circulation 1976. PMID: 786501


  526. Parmley WW, Chuck L, Chatterjee K, Swan HJ, Klausner C, Glantz SA. Acute changes in the diastolic pressure-volume relationship of the left ventricle. European journal of cardiology 1976. PMID: 819275


  527. Glantz SA, Luetscher JA, Day RP, Perloff M. A compartment description for cortisol secretion, distribution, binding, and metabolism in man. IEEE transactions on bio-medical engineering 1976. PMID: 172432


  528. Glantz SA, Kernoff RS. Muscle stiffness determined from canine left ventricular pressure-volume curves. Circulation research 1975. PMID: 1192570


  529. Winkle RA, Glantz SA, Harrison DC. Pharmacologic therapy of ventricular arrhythmias. The American journal of cardiology 1975. PMID: 1103605


  530. Glantz SA, Albers NV. Letters to the editor. Science (New York, N.Y.) 1975. PMID: 17755162


  531. Glantz SA. A three-element model describes excised cat papillary muscle elasticity. The American journal of physiology 1975. PMID: 1147020


  532. Glantz SA, Albers NV. Department of defense R & d in the university. Science (New York, N.Y.) 1974. PMID: 17792255


  533. Glantz SA. A constitutive equation for the passive properties of muscle. Journal of biomechanics 1974. PMID: 4837548


  534. Glantz SA, Mirsky I. Letter: Ventricular stiffness. Circulation research 1974. PMID: 4809346